BCAL Diagnostics Ltd Ordinary Shares BDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.11
- Day Range
- A$0.10–0.11
- 52-Week Range
- A$0.07–0.21
- Bid/Ask
- A$0.10 / A$0.11
- Market Cap
- A$25.23 Mil
- Volume/Avg
- 673,439 / 300,296
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.bcaldiagnostics.com
Valuation
|
Metric
|
BDX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.15 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BDX
|
|---|---|
Quick Ratio | 4.13 |
Current Ratio | 5.21 |
Interest Coverage | −132.88 |
Quick Ratio
BDX
Profitability
|
Metric
|
BDX
|
|---|---|
Return on Assets (Normalized) | −60.63% |
Return on Equity (Normalized) | −79.70% |
Return on Invested Capital (Normalized) | −69.62% |
Return on Assets
BDX
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Lxrdxjdzr | Gcllw | $206.7 Bil | |
DHR
| Danaher Corp | Kygzcypz | Rpvvpf | $175.0 Bil | |
IQV
| IQVIA Holdings Inc | Wnwrxsp | Hjtclq | $41.3 Bil | |
IDXX
| IDEXX Laboratories Inc | Yhnlbmkpn | Qfngybp | $39.7 Bil | |
A
| Agilent Technologies Inc | Bnwnbzhtl | Nvt | $38.8 Bil | |
MTD
| Mettler-Toledo International Inc | Ttzvkrpbq | Zybrz | $25.5 Bil | |
ICLR
| Icon PLC | Qqxnqmsjn | Wdvchj | $24.1 Bil | |
ILMN
| Illumina Inc | Fcdbqklt | Yqjchzr | $18.6 Bil | |
WAT
| Waters Corp | Jjpzhflmbh | Ttfs | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Qljtdtxyd | Xqdfvt | $16.8 Bil |